Advertisement

April 27, 2017

OEIS National Registry Launched to Track Data on Vascular Interventions

April 28, 2017—The Outpatient Endovascular and Interventional Society (OEIS) announced the launch of the OEIS National Registry to collect and report data for all office-based and outpatient interventions involving a fluoroscopic suite. The registry began enrolling patients in late December 2016.

Jeffrey G. Carr, MD, who serves as the OEIS National Registry's Medical Director, introduced the program with a presentation at the society's 4th annual national scientific meeting, held March 31 to April 1 in Santa Monica, California.

The registry is operated through OEIS, which is a nonprofit, multispecialty medical society formed in 2013 and composed of vascular surgeons, cardiologists, radiologists, and other qualified interventionists. More information about the OEIS National Registry is available online at www.oeisociety.org/oeis-registry.

According to the OEIS, the registry allows data collection and reporting in a unified, efficient format with established outcome measures designed for the unique needs of office and outpatient same-day interventions. Physicians can enroll patients at all their sites of service in which they perform interventions including the office, ambulatory surgery center, and hospital outpatient and inpatient locations.

The phase 1 rollout (called, "Data Essentials") encompasses all lower extremity peripheral vascular interventional procedures. Enrolling sites will be able to benchmark their data against a national database and use their own data for queries, costs, and quality improvement purposes.

The OEIS National Registry incorporates 10 quality measures and will be a Qualified Clinical Data Registry certified by the Centers for Medicare & Medicaid Services. This designation will allow the registry participants to satisfy the MIPS (Merit-Based Incentive Payment System) quality reporting requirements under MACRA.

In the OEIS announcement, Dr. Carr commented, “The registry provides a time- and cost-efficient option for centers to input and track their data in an intuitive, user-friendly manner. It allows participants to improve the quality of care and outcomes for their patients undergoing peripheral vascular intervention in all settings.”

Dr. Carr added, “It is increasingly important that we demonstrate the appropriateness, safety, and quality of the interventional procedures that we perform in all settings. This registry will be a platform for interventionists to not only report but also have meaningful feedback regarding their own lab’s demographics, indications, performance measures, and outcomes. The data regularly supplied back to the sites will provide a valuable tool to conduct quality improvement and analytics in a timely manner. The registry is designed with scalability (data enhanced), and will incorporate other modules and measures in the future.”

Advertisement


May 3, 2017

Clinical Study Begins for CE Mark Approval of Medeon's XPro Large-Bore Vascular Closure System

April 27, 2017

Data Presented for Biotronik's BIOFLEX PEACE and BIOLUX 4EVER Studies